Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
EXC 001, PF-06473871, PF-6473871
print preview
bookmark
share with colleague
General Information
Company
Isis Pharmaceuticals Inc.
Description
Antisense oligonucleotide targeting connective tissue growth factor (CTGF)
Molecular Target
Connective tissue growth factor (CTGF)
Mechanism of Action
Antisense therapy
Latest Stage of Development
Phase II
Indication
Scars / wrinkles
Partner
Pfizer Inc.
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy